Deep dissection of stemness-related hierarchies in hepatocellular carcinoma

被引:4
|
作者
Liang, Rui [1 ]
Hong, Weifeng [2 ]
Zhang, Yang [3 ]
Ma, Di [1 ]
Li, Jinwei [4 ]
Shi, Yisong [1 ]
Luo, Qing [1 ]
Du, Shisuo [2 ]
Song, Guanbin [1 ]
机构
[1] Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400030, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Radiat Oncol, 180 Fenglin Rd, Shanghai, Peoples R China
[3] Dali Univ, Affiliated Hosp 1, Gen Surg 1, Dali 671000, Peoples R China
[4] Guangxi Med Univ, Dept Neurosurg, Affiliated Hosp 4, Liuzhou 545000, Guangxi, Peoples R China
关键词
Hepatocellular carcinomas; Stemness; Molecule subtypes; Prognosis; Tumor microenvironment; Immunotherapy; Immune infiltration; mRNAsi; scRNA-seq; LPCAT1; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 1; CANCER; CELLS; PROGRESSION; EVOLUTION; HALLMARK; GROWTH; ATLAS; NICHE;
D O I
10.1186/s12967-023-04425-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundIncreasing evidence suggests that hepatocellular carcinoma (HCC) stem cells (LCSCs) play an essential part in HCC recurrence, metastasis, and chemotherapy and radiotherapy resistance. Multiple studies have demonstrated that stemness-related genes facilitate the progression of tumors. However, the mechanism by which stemness-related genes contribute to HCC is not well understood. Here, we aim to construct a stemness-related score (SRscores) model for deeper analysis of stemness-related genes, assisting with the prognosis and individualized treatment of HCC patients.Further, we found that the gene LPCAT1 was highly expressed in tumor tissues by immunohistochemistry, and sphere-forming assay revealed that knockdown of LPCAT1 inhibited the sphere-forming ability of hepatocellular carcinoma cells.MethodsWe used the TCGA-LIHC dataset to screen stemness-related genes of HCC from the MSigDB database. Prognosis, tumor microenvironment, immunological checkpoints, tumor immune dysfunction, rejection, treatment sensitivity, and putative biological pathways were examined. Random forest created the SRscores model. The anti-PD-1/anti-CTLA4 immunotherapy, tumor mutational burden, medication sensitivity, and cancer stem cell index were compared between the high- and low-risk score groups. We also examined risk scores for different cell types using single-cell RNA sequencing data and correlated transcription factor activity in cancer stem cells with SRscores genes. Finally, we tested core marker expression and biological functions.ResultsPatients can be divided into two subtypes (Cluster1 and Cluster2) based on the TCGA-LIHC dataset's identification of 11 stemness-related genes. Additionally, a SRscores was developed based on subtypes. Cluster2 and the group with the lowest SRscores had superior survival and immunotherapy response than Cluster1 and the group with the highest SRscores. The group with a high SRscores was significantly more enriched in classical tumor pathways than the group with a low SRscores. Multiple transcription factors and SRscores genes are correlated. The core gene LPCAT1 is highly expressed in rat liver cancer tissues and promotes tumor cell sphere formation.ConclusionA SRscores model can be utilized to predict the prognosis of HCC patients as well as their response to immunotherapy.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Assessing the prognostic value of stemness-related genes in breast cancer patients
    Wang, Wen-Jie
    Wang, Han
    Wang, Meng-sen
    Huang, Yue-Qing
    Ma, Yu-Yuan
    Qi, Jie
    Shi, Jian-Ping
    Li, Wei
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [32] Implications of stemness-related signaling pathways in breast cancer response to therapy
    Angeloni, Valentina
    Tiberio, Paola
    Appierto, Valentina
    Daidone, Maria Grazia
    SEMINARS IN CANCER BIOLOGY, 2015, 31 : 43 - 51
  • [33] Stemness-related gene signatures as a predictive tool for breast cancer radiosensitivity
    Lai, Jinzhi
    Huang, Rongfu
    Huang, Jingshan
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [34] Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
    Li, Xiaoying
    Li, Yang
    Yu, Xinmiao
    Jin, Feng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [35] Expression Pattern of Stemness-Related Genes in Human Endometrial and Endometriotic Tissues
    Amalia Forte
    Maria Teresa Schettino
    Mauro Finicelli
    Marilena Cipollaro
    Nicola Colacurci
    Luigi Cobellis
    Umberto Galderisi
    Molecular Medicine, 2009, 15 : 392 - 401
  • [36] Assessing the prognostic value of stemness-related genes in breast cancer patients
    Wen-Jie Wang
    Han Wang
    Meng-sen Wang
    Yue-Qing Huang
    Yu-Yuan Ma
    Jie Qi
    Jian-Ping Shi
    Wei Li
    Scientific Reports, 10
  • [37] Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma
    Huang, Runzhi
    Li, Zhenyu
    Zhang, Jiayao
    Zeng, Zhiwei
    Zhang, Jiaqi
    Li, Mingxiao
    Wang, Siqao
    Xian, Shuyuan
    Xue, Yuna
    Chen, Xi
    Li, Jie
    Cheng, Wenjun
    Wang, Bin
    Yan, Penghui
    Yang, Daoke
    Huang, Zongqiang
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [38] Induced Pluripotent Reprogramming from Promiscuous Human Stemness-Related Factors
    Nelson, Timothy J.
    Martinez-Fernandez, Almudena
    Yamada, Satsuki
    Mael, Amber A.
    Terzic, Andre
    Ikeda, Yasuhiro
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2009, 2 (02): : 118 - 126
  • [39] Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
    Xiaoying Li
    Yang Li
    Xinmiao Yu
    Feng Jin
    Journal of Translational Medicine, 18
  • [40] Universal and stemness-related tumor antigens: Potential use in cancer immunotherapy
    Parmiani, Giorgio
    Russo, Vincenzo
    Marrari, Andrea
    Cutolo, Gianluca
    Casati, Chiara
    Pilla, Lorenzo
    Maccalli, Cristina
    Rivoltini, Licia
    Castelli, Chiara
    CLINICAL CANCER RESEARCH, 2007, 13 (19) : 5675 - 5679